Research Article
Validation of Serum Biomarkers Derived from Proteomic Analysis for the Early Screening of Preeclampsia
Table 1
Maternal and neonatal characteristics of cases and controls included in the study [
17].
| | Controls ( = 48) | PE ( = 24) | Statistics |
| Maternal age (y) | 32.2 28.8–37.3 | 32.9 27.3–35.0 | NS | Prepregnancy BMI (kg/m2) | 24.8 22.5–26.2 | 27.9 23.4–32.9 | = .000 | Cigarette smoker | 35 (73%) | 12 (50%) | = .028 | Nulliparous | 29 (60.4%) | 22 (91.6%) | = .013 |
Parous | 19 (39.6%) | 2 (8.4%) | Family history of PE | 0 | 0 | — | Conception | | | | Spontaneous | 42 (87.5%) | 24 (100%) | = .090 | IVF | 6 (12.5%) | 0 | Medical history | | | | Diabetes mellitus | 0 | 0 | — | Thrombophilia | 0 | 1 | Mode of delivery | | | | Vaginal birth () | 33 (68.7%) | 8 (33.3%) | = .013 | Caesarean delivery () | 15 (31.3%) | 16 (66.6%) | Gestational age at delivery (wk) | 40.2 37.2–42.0 | 38.1 32.1–40.6 | | <37 wk () | 0 | 7 | = .000 | <34 wk () | 0 | 2 | Birth weight (g) | 3410 2880–4250 | 2780 980–3950 | | >10th percentile () | 48 | 11 | = .020 | <10th percentile () | 0 | 11 | <5th percentile () | 0 | 2 |
|
|